Volume 10, Number 1—January 2004
Human Infection with M- Strain of Brucella canis
|Antigen||Lymphocyte proliferation (SI)||IL-2b (fold increase)||IFN-γb (fold increase)||IL-10b (fold increase)|
|End of therapy||BLS||1||1||2||1|
|55 days after end of therapy||BLS||1||1||1||1|
aBLS, Brucella lumazine synthase; CP, cytoplasmic proteins; SI, stimulation indices; IL, interleukin; IFN, interferon.
bBy reverse transcription-polymerase chain reaction.
- Page created: December 21, 2010
- Page last updated: December 21, 2010
- Page last reviewed: December 21, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)